Major causes of head and neck squamous cell carcinoma (HNSCC)-related deaths are cervical node and distant metastasis. We previously demonstrated that overexpression of the DNA double-strand break repair protein Nijmegen breakage syndrome 1 (NBS1) is a prognostic marker of advanced HNSCCs. Epithelial-mesenchymal transition (EMT) was demonstrated to be the major mechanism responsible for mediating invasiveness and metastasis of late-stage cancers. We therefore investigated the role of NBS1 overexpression in mediating EMT and metastasis. NBS1 overexpression was associated with metastasis of HNSCC patients using tissue microarrayimmunohistochemistry approach. Induction of EMT was observed in an NBS1-overexpressing HNSCC cell line (FADUNBS), whereas short-interference RNA (siRNA)-mediated repression of endogenous NBS1 reversed the shift of EMT markers. Increased migration/invasiveness of FADUNBS was shown by in vitro and in vivo assays. NBS1 overexpression upregulated the expression of an EMT regulator Snail and its downstream target matrix metalloproteinase-2. EMT phenotypes and increased migration/invasiveness of FADUNBS cells were reversed by siRNA-mediated repression of Snail expression or a phosphatidylinositol 3-kinase-specific inhibitor. In HNSCC samples, co-expression of NBS1/Snail in primary tumors correlated with metastasis and the worst prognosis. These results indicate that NBS1 overexpression induces EMT through the upregulation of Snail expression, and coexpression of NBS1/Snail predicts metastasis in HNSCCs.
Major causes of head and neck squamous cell carcinoma (HNSCC)-related deaths are cervical node and distant metastasis. We previously demonstrated that overexpression of the DNA double-strand break repair protein Nijmegen breakage syndrome 1 (NBS1) is a prognostic marker of advanced HNSCCs. Epithelial-mesenchymal transition (EMT) was demonstrated to be the major mechanism responsible for mediating invasiveness and metastasis of late-stage cancers. We therefore investigated the role of NBS1 overexpression in mediating EMT and metastasis. NBS1 overexpression was associated with metastasis of HNSCC patients using tissue microarrayimmunohistochemistry approach. Induction of EMT was observed in an NBS1-overexpressing HNSCC cell line (FADUNBS), whereas short-interference RNA (siRNA)-mediated repression of endogenous NBS1 reversed the shift of EMT markers. Increased migration/invasiveness of FADUNBS was shown by in vitro and in vivo assays. NBS1 overexpression upregulated the expression of an EMT regulator Snail and its downstream target matrix metalloproteinase-2. EMT phenotypes and increased migration/invasiveness of FADUNBS cells were reversed by siRNA-mediated repression of Snail expression or a phosphatidylinositol 3-kinase-specific inhibitor. In
Introduction
Head and neck squamous cell carcinoma (HNSCC) represents the sixth most frequent type of cancer worldwide and remains a challenging oncology problem (Jemal et al., 2003) . It is one of the leading causes for male cancer death in Taiwan (Department of Health, the Executive Yuan, ROC, 2005) . HNSCC-related death is mainly caused by cervical lymph node metastasis, and occasionally by distant organ metastasis (Leemans et al., 1993) . Molecular markers such as VEGF and nitric oxide were reported to be associated with the metastasis of HNSCC (Sauter et al., 1999; Bentz et al., 2000) . However, few reports have applied the markers clinically to predict metastasis, and the molecular mechanisms mediating metastasis of HNSCC remain largely unknown. Delineation of the mechanisms involved in the metastasis and identification of molecular markers that can pinpoint patients with biologically aggressive tumors will be of the utmost importance for effective management of HNSCC patients.
Nijmegen breakage syndrome (NBS) is a chromosomal-instability syndrome associated with cancer predisposition, radiosensitivity and growth retardation (D'Amours and Jackson, 2002) . The NBS gene product, NBS1, is a part of the hMre11 complex, which plays a central role in DNA double-strand break repair (D'Amours and Jackson, 2002) . We previously demonstrated that c-MYC oncoprotein directly activates NBS1 expression (Chiang et al., 2003) , and overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol (PI) 3-kinase/Akt (Chen et al., 2005) . Increased NBS1 expression is present in 45% of advanced HNSCC patients and is associated with a poor prognosis (Yang et al., 2006) . These results indicate that NBS1 overexpression may participate in late-stage progression and metastasis of HNSCC and contributes to poor prognosis in HNSCC patients.
The transcriptional repressor Snail is one of the master regulators, which mediate invasiveness and metastasis of different types of human cancer (Batlle et al., 2000; Moody et al., 2005) . Snail transcription is promoted by Akt to induce epithelial-mesenchymal transition (EMT), a process by which epithelial cells lose their polarity and are converted to a mesenchymal phenotype (Barbera`et al., 2004; Zhou et al., 2004; Larue and Bellacosa, 2005) . EMT is demonstrated to be one of the central mechanisms to induce invasiveness and metastasis of tumors (Thompson et al., 2005; Thiery and Sleeman, 2006) . Snail induces EMT by repressing Ecadherin transcription through binding to the E-box in the E-cadherin promoter (Batlle et al., 2000; Cano et al., 2000) . E-cadherin repression by Snail is a characteristic of highly invasive and metastatic cancers (Batlle et al., 2000) . In addition, Snail induces matrix metalloproteinase-2 (MMP-2) expression and contributes to increased invasiveness through the inhibition of cell-cell adhesion (Yokoyama et al., 2003) .
In this report, we demonstrated that NBS1 overexpression is associated with metastasis of HNSCC patients. NBS1 overexpression induces EMT and increases invasiveness/metastasis both in vitro and in vivo, whereas short-interference RNA (siRNA)-mediated repression of endogenous NBS1 reverses the shift of EMT markers. NBS1 overexpression upregulates Snail/MMP-2 expression and increases MMP-2 activity, which is reversed by siRNA-mediated repression of Snail expression or a PI 3-kinase-specific inhibitor (LY294002). In HNSCC samples, co-expression of NBS1 and Snail in primary tumors correlates with a higher probability of metastasis and the worst prognosis. These results indicate that NBS1 overexpression induces EMT through the upregulation of Snail/ MMP-2 expression, and co-expression of NBS1 and Snail predicts metastasis in HNSCC cases.
Results
Increased NBS1 expression is associated with metastasis of HNSCC cases As NBS1 overexpression is associated with a poor prognosis of HNSCC (Yang et al., 2006) and the major causes of HNSCC-related death are cervical node or distant metastasis (Leemans et al., 1993) , we speculated the possible link between increased NBS1 expression and metastasis of HNSCC. To investigate this correlation, tissue microarray-immunohistochemistry (TMA-IHC) analysis of NBS1 expression in primary/metastatic HNSCC and non-cancerous matched tissue (NCMT) of 147 patients was performed. No NBS1 cytoplasmic staining could be detected in NCMT (Figure 1a (N) ), whereas 38.1% primary and 87.1% metastatic tumors showed NBS1-positive staining (Figure 1a (T), 1a (M)). A significantly higher NBS1 IHC-positive rate was observed in metastatic tumor samples compared with primary HNSCCs and NCMT (Figure 1b) , and Western blot analysis showed increased NBS1 expression in metastatic lesions in representative cases ( Figure 1c) . A significantly higher incidence of cervical node metastasis at diagnosis (P ¼ 0.010) and distant metastasis after surgery (Po0.001) was observed in NBS1 overexpression cases (Table 1) . A significantly shorter metastasisfree period was also demonstrated in NBS1-positive group (Po0.001, Figure 1d ). All these results demonstrated that increased NBS1 expression is associated with lymph node/distant metastasis in HNSCC patients.
NBS1 overexpression induces EMT
Activation of PI 3-kinase/Akt by NBS1 overexpression (Chen et al., 2005) and constitutive expression of to EMT phenotypes including downregulation of the epithelial marker E-cadherin and upregulation of the mesenchymal marker vimentin. Immunofluorescence staining demonstrated that loss of cell-to-cell junction E-cadherin and increase in cytoplasmic vimentin expression were observed in FADUNBS cells (Figure 2b ). Morphological observations showed that FADUCMV cells preserved a relatively higher cell-cell adhesion and polarity, whereas FADUNBS cells exhibited a shift to fibroblastic-like morphology and more scattering (data not shown). To further confirm that NBS1 overexpression correlated with the shift of EMT markers, representative epithelial and mesenchymal markers were examined in an inducible NBS1-knockdown cell line (FADUNBSi). Repression of a non-related protein (topoisomerase IIIa) by siRNA was used as a negative control (FADU-top3ai). The results showed that repression of endogenous NBS1 expression in FADUNBSi cells caused an increase in E-cadherin expression and a decrease in vimentin expression (Figure 2c ). These results indicated that overexpression of NBS1 induces EMT in HNSCC cells.
NBS1 overexpression increases migration/invasiveness and metastatic ability of HNSCC cells
To demonstrate the increased migration/invasiveness in NBS1-overexpressing cells, Boyden chamber migration and matrigel invasion assay were performed. The results showed that NBS1 overexpression increased the migration and invasiveness of FADU cells (Figure 3a-c) . siRNA-mediated repression of NBS1 expression suppressed the invasion/migration of FADU cells (Supplementary Figure 1) . To test whether NBS1 overexpression indeed increases the metastatic ability in vivo, a tail vein metastasis assay was performed. After 4 weeks of injection, the lungs of the mice receiving FADUNBS cells had significantly more metastatic nodules compared with the mice receiving FADUCMV cells (Figure 3d, f) . The nodules in the lungs of the control group were smaller than those appearing in the experimental group (Figure 3d ). There were no metastatic nodules in the liver in either the experimental or control group (data not shown). The gross observation of metastatic nodules in the lungs was confirmed by histological examination (Figure 3e ). All these results demonstrated that NBS1 overexpression in HNSCC cells increases migration/invasiveness in vitro and metastasis in vivo.
Overexpression of NBS1 upregulates the expression of Snail/MMP-2 As NBS1 overexpression activates PI 3-kinase/Akt (Chen et al., 2005) and Akt induces Snail expression (Barbera`et al., 2004) , induction of EMT by NBS1 overexpression may be mediated by the upregulation of Snail expression. The mRNA and protein expression Figure 3) . In order to test whether the upregulation of Snail/MMP-2 in FADUNBS cells can be blocked by a PI 3-kinase-specific inhibitor (LY294002), Western blot, zymography and migration/invasion assays were performed to evaluate the effect of PI 3-kinase inhibition.
The results showed that inhibition of PI 3-kinase caused the repression of Snail expression (Figure 5d ), the reversion of EMT markers (Figure 5d) , and a decrease in MMP-2 activity (Figure 5e ) and migration/invasiveness ability (Figure 5f ). All these results indicated that induction of EMT and migration/invasiveness by NBS1 overexpression could be reversed through the inhibition of the PI 3-kinase/Akt/Snail axis.
Co-expression of NBS1 and Snail predicts metastasis and the worst prognosis of HNSCC In order to evaluate the clinical significance of Snail expression and its association with NBS1 in HNSCC, TMA-IHC analysis was performed. Increased Snail expression was identified in 55 (37.4%) primary HNSCC samples, and it was associated with cervical node and distant metastasis (P ¼ 0.019, Po0.001, respectively; Table 1 ). High proportion of co-expression of NBS1/Snail was found in metastatic tumor samples (82.1%) compared with primary ones (18.3%) ( Table 2; representative IHC picture in Figure 6a ). NBS1 and Snail co-expression in primary HNSCCs correlated with a higher probability of metastasis compared with other patient groups (83.3 vs 22.2%, Po0.001), and indicated the shortest metastasis-free period (Figure 6b ). In addition, the patient group of NBS1/Snail co-expression also had the shortest overall survival period (Po0.001).
The independent prognostic effect of co-expression was confirmed by multivariate analysis (hazard ratio ¼ 2.83, P ¼ 0.047). These results indicated that increased NBS1/ Snail co-expression is associated with HNSCC metastasis and the worst overall survival.
Discussion
In this paper, we demonstrated that increased NBS1 expression causes late-stage progression and metastasis of HNSCC from the following evidences: (1) NBS1 overexpression in both the primary and metastatic tumors, and significantly higher NBS1 IHC-positive rate in metastatic samples ( Figure 1) ; (2) significant association of NBS1 overexpression with HNSCC metastasis (Table 1) ; (3) a significantly shorter metastasis-free period in the NBS1-positive group ( Figure 1d) ; (4) induction of EMT by NBS1 overexpression and reversion of EMT by repression of NBS1 expression ( Figure 2) ; (5) increase in migration/invasiveness and metastatic ability by NBS1 overexpression (Figure 3 ). Previous reports suggested that lung tissue is the most frequent site of distant metastases in HNSCC patients (Ferlito et al., 2001) , which is consistent with our results that NBS1 overexpression in HNSCC cells enhanced the development of pulmonary metastasis. Our results suggest that the unfavorably prognostic effect of NBS1 overexpression may be due to the induction of EMT by NBS1 overexpression. 
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We demonstrated that NBS1 overexpression induces EMT and increases invasiveness from the following evidences: (1) Figure 2) ; (2) siRNA-mediated repression of Snail expression or inhibition of PI 3-kinase in FADUNBS cells reverses the EMT phenotypes, decreases MMP-2 activity and suppresses the in vitro migration/invasiveness ( Figure 5 ) and in vivo metastatic ability (Supplementary Figure 3) ; (3) a significant correlation between NBS1 and Snail expression in HNSCC metastatic tumor samples (Table 2) , and co-expression of NBS1 and Snail in primary tumors indicating a significant risk of metastasis and the worst survival ( Figure 6 ). Increased Snail expression in HNSCCs may be due to the activation by Akt or other mechanisms, as B30% of patients developing metastasis belonged to the Snail( þ )/ NBS1(À) group. On the contrary, NBS1 may activate other pathways that promote EMT/metastasis, as B9% of metastatic HNSCC cases belonged to the NBS1( þ )/ Snail(À) group in our study (data not shown). 
NBS1 overexpression induces EMT in head and neck cancers
M-H Yang et al NBS1 deficiency in human cells leads to hypermutability and telomere associations, phenotypes that may contribute to cancer predisposition (Zhang et al., 2005) . Our results showed that depletion of NBS1 in NBS1-overexpressing cancer cells, but not normal cells, would have therapeutic potential to decrease metastasis. Therefore, the perturbation of NBS1 during cancer therapy should be cautioned and monitored according to the NBS1 expression status. Akt activation in NBS1-overexpressing cells could cause genomic instability by overcoming a G2/M cell cycle checkpoint or sequestering checkpoint kinase 1 (Kandel et al., 2002; Puc et al., 2005) . However, the role of NBS1 overexpression in causing genomic instability independent of Akt pathway remains to be explored.
In conclusion, our results demonstrated that overexpression of NBS1 induces EMT through the upregulation of Snail/MMP-2, leading to the development of metastasis and poor prognosis of HNSCC patients. Inhibition of PI 3-kinase/Akt/Snail axis in NBS1-overexpressing HNSCC cells reverses EMT and suppresses their invasiveness and metastatic ability. Co-expression of NBS1 and Snail indicates a significant risk of metastasis and the worst overall survival. This discovery provides valuable information for the diagnosis/ prognosis and future target of antimetastasis therapy in HNSCC patients.
Materials and methods

Study population and sample collection
One hundred and forty-seven patients with HNSCC who underwent treatment at Taipei Mackay Memorial Hospital and Taipei Veterans General Hospital between January 2001 and August 2004 were enrolled in this study. This study was approved by the Institutional Review Board of both hospitals. All patients had histologically proven HNSCCs, which were likely to be cured with surgery, or a combination of surgery and postoperative radiotherapy (PORT). Primary tumor samples and the corresponding NCMT were obtained during surgery, whereas 56 metastatic tumor samples were obtained from biopsy/salvage neck dissection when metastasis occurred. Patients with T1-2N0M0 disease received wide excision of primary tumor (n ¼ 54), and those with T3-4NxM0 disease received primary tumor excision, neck dissection and PORT (n ¼ 93). The median follow-up duration was 25 months (range, 10-55 months). The clinical characteristics of 147 HNSCC patients are illustrated in Table 1 .
TMA construction
A high-density TMA was constructed using formalin-fixed, paraffin-embedded specimens of primary HNSCC, metastatic NBS1 overexpression induces EMT in head and neck cancers M-H Yang et al tumor and NCMT as described previously (Kononen et al., 1998) . Two pathologists (Drs TY Chou and WY Li from Taipei Veterans General Hospital) evaluated the tissue sections by routine hematoxylin and eosin (H&E) staining and identified the regions of interest (HNSCC, NCMT and metastatic tumors) for IHC analysis.
IHC and scoring
The procedures of deparaffinization, rehydration, antigen retrieval, IHC staining and pathology scoring were performed as described (Yang et al., 2006) . The NBS1 IHC scoring was assigned according to our recent report (Yang et al., 2006) . For interpretation of Snail IHC result, X25% of cytoplasmic expression was considered as positive Snail expression with reference to the previous report (Martin et al., 2005) . The characteristics of the antibodies used are listed in the Supplementary Table 1 .
Protein extraction, Western blot and immunoprecipitation
The procedures of protein extraction from patient samples and cell lines and Western blot analysis were performed as described (Yang et al., 2006) . To increase the stability of Snail, 10 mM MG-132 was added to cells and incubated for 5 h before harvesting . Immunoprecipitation procedure was performed as described (Chiang et al., 2003) with an anti-Snail antibody. Data shown here are representative of two or more experiments from independent cell cultures. The characteristics of the antibodies used are listed in the Supplementary Table 1.
Plasmids, transfection and cell lines
The human HNSCC cell lines FADU, FADUNBS and doxycycline inducible FADUNBSi were described previously (Yang et al., 2006) . The pSUPER-top3ai plasmid was described (Tsai et al., 2006) . The plasmid pSUPER-Snaili was generated by inserting the oligonucleotide of 5 0 -GATCCCCCACCTCCGGAGATCCTCAATTCAAGAGAT TGAGGATCTCCGGAGGTGTTTTTA-3 0 into the pSUPER plasmid. The FADUNBS-Snaili cell lines were generated by transfecting the pSUPER-Snaili plasmid into FADUNBS cells and selected under puromycin (0.25 mg/ml). The pHeBOCMV, pSUPERIOR and pSUPER plasmids were stably transfected into FADU cells to generate the vector control cell lines. Repression of a non-related protein (toposiomerase IIIa) (Tsai et al., 2006) was achieved by stable transfection of the pSUPER-top3ai plasmid into FADU or FADUNBS cells. FADU-top3ai or FADUNBS-top3ai clone was used as a negative control in siRNA experiments.
RNA purification and real-time PCR analysis RNA purification and cDNA synthesis were performed as described (Yang et al., 2006) . To evaluate the mRNA expression of NBS1, Snail and MMP-2 in different cell lines and HNSCC samples, quantitative real-time PCR was performed as described (Chen et al., 2005; Yang et al., 2006) . The primer sequences used in real-time PCR were shown in the Supplementary Table 2. Immunofluorescence For immunofluorescence microscopy, cells on glass coverslips were fixed in 4% formaldehyde, washed with phosphatebuffered saline (PBS) and permeated with 0.01% Triton X-100. After washing with PBS, samples were incubated with blocking solution for 1 h, followed by 1 h of incubation with an anti-E-cadherin antibody and an anti-vimentin antibody. Fluorescein isothiocyanate-conjugated goat anti-rabbit immunoglobulin G (IgG) and rhodamine-conjugated goat anti-mouse IgG were used to visualize the location of E-cadherin and vimemtin, respectively. Cell nuclei of cultures were counterstained with Hoechst 33342 (Sigma-Aldrich Corp., St Louis, MO, USA) and fluorescence images were captured using a Leica laser scanning confocal microscope. The characteristics of the antibodies used are listed in the Supplementary Table 1 .
Cell migration and invasiveness assay Eight-mm pore size Boyden chamber was used for in vitro migration and invasion assays. Cells (1 Â 10 5 ) in 0.5% serumcontaining Roswell Park Memorial Institute (RPMI) medium were plated in the upper chamber and 15% fetal bovine serum was added to RPMI 1640 in the lower chamber as a chemoattractant. For invasion assay, the upper side of the filter was covered with Matrigel (Collaborative Research Inc., Boston, MA, USA) (1:3 dilution with RPMI). After 12 h for migration assay or 24 h for invasion assay, cells on the upper side of the filter were removed, and cells that remained adherent to the underside of membrane were fixed in 4% formaldehyde and stained with Hoechst 33342 dye. The number of migrated cells was counted using a fluorescence microscope. Ten contiguous fields of each sample were examined using a Â 40 objective to obtain a representative number of cells which migrated/invaded across the membrane.
Gelatin zymography
Gelatin zymography was performed by subjecting 5 mg of each conditioned media sample to 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis containing 0.1% gelatin (G-9382, Sigma-Aldrich Corp., St Louis, MO, USA) as described previously (Lu et al., 2004) . Gels were stained with Coomassie Brilliant Blue R-250 and then destained. Transparent bands identified at 72 kDa (latent form of MMP-2) and 66 kDa (active form of MMP-2) on the Coomassie Blue background of the gel were considered positive for the presence of enzymatic activity.
In vivo tail vein metastasis assay Six-week-old female non-obese diabetic severe-combined immunodeficiency (NOD-SCID) mice received injection of 4 Â 10 6 cells of FADUCMV vs FADUNBS or FADUNBS vs FADUNBS-Snaili in 0.1 ml of PBS via the tail vein (six mice for each group). Four weeks after injection, mice were examined grossly at necropsy for the presence of metastases in internal organs. Microscopic examination of metastases was performed on the cross-sections of formalin-fixed, paraffinembedded lung tissues stained with H&E. The counting of metastatic lesions in the internal organ of each mouse was evaluated by gross and microscopic examination. This study was approved by the Ethics Committee of the Taipei Veterans General Hospital.
Statistical analysis
Pearson w 2 or Fisher's exact tests were used for comparison of dichotomous variables, whereas the independent Student's t-test or analysis of variance was used to compare the continuous variables between groups. The Kaplan-Meier estimate was used for survival analysis, and the log-rank test was selected to compare the cumulative survival durations in different patient groups. The multivariate Cox's proportional hazards model was applied to test the independent prognostic factors. The level of statistical significance was set at 0.05 for all tests.
